Adult Immunization
Latest News
Dec 29, 2025 | Feature
Caregiver Education on Alzheimer Agitation Is Essential: A Q&A with Geriatric Nurse Practitioner Carolyn Clevenger
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
Dec 26, 2025
This Year in Primary Care: 10 Critical Updates in 2025
Dec 23, 2025
FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management
Dec 23, 2025
FDA Approves Abbott Volt Pulsed Field Ablation System for Treatment of Atrial Fibrillation
Dec 22, 2025
Advertisement
Shorts
0:55
“Eight Pills Was Fine—Nine Wasn’t”: Real Patients, Real PrEP Decisions
11 days ago
by
Kevin Hatfield, MD
0:45
Stool-Based CRC Tests? 21 Karat Gold, Says Mark Fendrick, MD
12 days ago
by
Mark Fendrick, MD
0:31
The Hidden HIV Crisis: 1 in 5 New Cases Are in Cisgender Women
13 days ago
by
Kevin Hatfield, MD
0:49
Why Patients Struggle With Daily Oral PrEP
14 days ago
by
Kevin Hatfield, MD
0:39
Why Clinician Education is Needed on Hormone Replacement Therapy
17 days ago
by
Bruce Dorr, MD, URPS, IFM-CP(+1 more)
0:39
Why Agitation Must be Prioritized in Alzheimer's Care
21 days ago
by
Carolyn Clevenger, GNP
1:05
Menopause Symtpoms Could Drive Women to Leave Work
24 days ago
by
Bruce Dorr, MD, URPS, IFM-CP
0:38
How to Counter Vaccine Misinformation in Clinical Practice
25 days ago
by
Amesh Adalja, MD
0:33
The iPhone Analogy: Reframing Vaccines as Essential, Life-Navigating Technology
25 days ago
by
Amesh Adalja, MD
0:44
Perimenopause Symptoms Often Start Around Age 42
a month ago
by
Bruce Dorr, MD, URPS, IFM-CP
Exclusive Survey Results: Screening For Cognitive Decline in Primary Care
New survey finds that most PCPs screen for mild cognitive impairment, but time is an issue, guidelines are few, and low levels of confidence persist.
2025 Postoperative Pain Management: Progress and Process
Latest Videos
Podcasts
Screening
All News
Advertisement
Advertisement
Topline Phase 3 ATTAIN-MAINTAIN data show oral orforglipron met primary and key secondary endpoints for weight maintenance after prior GLP-1–based injectable therapy in adults with obesity.
Completion of the screening pathway—not test selection alone—may define quality going forward.
Real-world patient cases illustrating how pill burden, privacy, and individual preferences influence PrEP selection and adherence.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Phase 3 LIBerate data showed sustained LDL-C reductions of 60% or more in high-risk patients and 50% or more in HeFH, with once-monthly self-administration.
Primary care physician Kevin Hatfield, MD, discusses how the switch can increase patient touchpoints, free cognitive burden, and strengthen long-term engagement between patients and PCPs.
Moving patients from considering screening to completing it remains the central challenge in colorectal cancer prevention, Fendrick explained to Patient Care.
Advertisement
Advertisement